Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eledon Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 150K | Oct 2, 2023 | Direct | ||
UroGen Pharma Ltd. | Director | Stock Option (right ot buy) | 10K | Aug 6, 2024 | Direct | ||
APPLIED GENETIC TECHNOLOGIES CORP | Director | Stock Option (Right to Buy) | 0 | Nov 30, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
URGN | UroGen Pharma Ltd. | Aug 6, 2024 | 1 | $0 | 4 | Aug 8, 2024 | Director |
ELDN | Eledon Pharmaceuticals, Inc. | Oct 2, 2023 | 1 | $233K | 4 | Oct 3, 2023 | Director |
ELDN | Eledon Pharmaceuticals, Inc. | Oct 1, 2023 | 0 | $0 | 3 | Oct 2, 2023 | Director |
URGN | UroGen Pharma Ltd. | Sep 7, 2023 | 1 | $0 | 4 | Sep 8, 2023 | Director |
URGN | UroGen Pharma Ltd. | Jul 25, 2023 | 1 | $0 | 4/A | Jul 28, 2023 | Director |
URGN | UroGen Pharma Ltd. | Jul 25, 2023 | 0 | $0 | 3 | Jul 27, 2023 | Director |
AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Nov 30, 2022 | 1 | $0 | 4 | Dec 1, 2022 | Director |
AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Nov 30, 2021 | 1 | $0 | 4 | Dec 2, 2021 | Director |
AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Nov 30, 2021 | 0 | $0 | 3 | Dec 2, 2021 | Director |